Drinking coffee could reduce the risk of type 2 diabetes, according to a report published by the Institute for Scientific Information on Coffee.
Coffee consumption of at least three to four cups a day, whether caffeinated or not, may reduce diabetes risk by up to 25% compared to drinking no coffee or less than two cups a day. Each cup of coffee supposedly lowers risk by 7-8%.
“Research has found that coffee consumption is associated with lower C-peptide, especially in the overweight or obese, with higher levels of adiponectin and with lower levels of inflammatory markers,” the report stated. “Coffee consumption could play a distinct role in glucose metabolism.”
Additionally, there is a “dose-dependent, inverse association” between drinking coffee and total mortality in not only the general population but also patients with diabetes.
Previous studies have shown that moderate consumption of coffee could help to prevent cancer of the prostate, pancreas, breast, as well as Alzheimer’s disease.
The Institute for Scientific Information on Coffee is a nonprofit organization made up of seven major European coffee companies.
Drinking three to four cups of coffee every day could reduce the risk of type 2 diabetes.
Here’s some sweet news for those who love the bitter taste of coffee: According to a new study, drinking three to four cups a day can slash the risk of Type 2 diabetes by 25 percent. That’s compared with drinking no coffee or less than two cups a day. And it doesn’t have to be caffeinated coffee, either.
“A recent meta-analysis suggested that consumption of both caffeinated and decaffeinated coffee is associated with a lower risk of Type 2 diabetes,” the study says. The research was performed by the Institute for Scientific Information on Coffee — a nonprofit organization made up of seven of the major European coffee companies — and published Nov. 14. According to the group, each cup of coffee lowers your risk of Type 2 diabetes by 7 to 8 percent.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.